Procedure Codes A4261: Cervical cap for contraceptive use A4266: Diaphragm for contraceptive use A4264: Permanent implantable contraceptive intratubal occlusion device(s) and delivery system J7300: Intrauterine copper contraceptive J7301: Levonorgestrel-releasing intrauterine contraceptive system (skyla), 13.5 mg J7303: Contraceptive supply, hormone containing vaginal ring, each J7304: Contraceptive supply, hormone containing patch, each J7306: Levonorgestrel (contraceptive) implant system, including implants and supplies J7307: Etonogestrel (contraceptive) implant system, including implant and supplies J7296: Levonorgestrel-releasing intrauterine contraceptive system, (kyleena), 19.5 mg J7297: Levonorgestrel-releasing intrauterine contraceptive system (liletta), 52 mg J7298: Levonorgestrel-releasing intrauterine contraceptive system (mirena), 52 mg J1050: Injection, medroxyprogesterone acetate, 1 mg 00851: Anesthesia for intraperitoneal procedures in lower abdomen including laparoscopy; tubal ligation/transection 11976: Removal, implantable contraceptive capsules 11981: Insertion, non-biodegradable drug delivery implant 11982: Removal, non-biodegradable drug delivery implant 11983: Removal with reinsertion, non-biodegradable drug delivery implant
57170: Diaphragm or cervical cap fitting with instructions 58300: Insertion of intrauterine device (IUD 58301: Removal of intrauterine device (IUD) 58340: Catheterization and introduction of saline or contrast material for saline infusion sonohysterography (SIS) or hysterosalpingography 58565: Hysteroscopy, surgical; with bilateral fallopian tube cannulation to induce occlusion by placement of permanent implants 58600: Ligation or transection of fallopian tube(s), abdominal or vaginal approach, unilateral or bilateral 58605: Ligation or transection of fallopian tube(s), abdominal or vaginal approach, postpartum, unilateral or bilateral, during same hospitalization (separate procedure) 58611: Ligation or transection of fallopian tube(s) when done at the time of cesarean delivery or intra-abdominal surgery (not a separate procedure) (List separately in addition to code for primary procedure) 58615: Occlusion of fallopian tube(s) by device (eg, band, clip, Falope ring) vaginal or suprapubic approach 58670: Laparoscopy, surgical; with fulguration of oviducts (with or without transection) 58671: Laparoscopy, surgical; with occlusion of oviducts by device (eg, band, clip, or Falope ring) 74740: Hysterosalpingography, radiological supervision and interpretation 76830: Ultrasound, transvaginal 96372: Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular
Visits for side-effects should be coded with codes 99201-99215, as supported with the documentation, with modifier 33
Not covered by Medicare for preventative care, consult your payer for full guidelines
Find-A-Code™ - Preventive Services - The information in this document does not guarantee payment or that included codes meet applicable qualifications as preventive services for all insurances and insurance plans, please consult your payer.
###
Questions, comments?
If you have questions or comments about this article please contact us. Comments that provide additional related information may be added here by our Editors.
If you are not seeing a CCI edit when reporting an E/M code with a certain procedure, it may be that there is no edit. CMS does not have a CCI edit for every CPT code, however, there are still general coding rules that must be followed.
The use of Modifier 25 is one example ...
To determine the dosage, size, doses per package and how many billing units are in each package, refer to the NDC number.
Take a look at the following
J1071 - Injection, testosterone cypionate, 1mg
For example; using NCD # 0009-0085-10 there are 10 doses of 100 mL
(100 mg/mL = 1 mL and there are ...
As we begin returning back to work, we will all face a new normal. The COVID-19 pandemic has changed the face of business. While it has certainly been a challenge to keep up with the ever-changing regulations (that’s likely to continue for a little longer), exciting new opportunities have also been created, such as the expansion of telemedicine. There’s also the maze of government funding that needs to be navigated and an increased awareness of OSHA standards to implement.
The CDC has released additional information and coding guidance for reporting encounters related to the 2019 health care encounters and deaths related to e-cigarette, or vaping, product use associated lung injury (EVALI).
The update offers coding scenarios for general guidance, poisoning and toxicity, substance abuse and signs and symptoms.
ICD-10-CM Official Coding Guidelines - ...
On April 30, 2020, CMS announced additional sweeping changes to meet the challenges of providing adequate healthcare during this pandemic. These changes expand the March 31st changes. The article covers some of the key changes. See the official announcement in the references below.
Risk adjustment is simply a way of making sure that there are sufficient funds to adequately take care of the healthcare needs of a certain population. It’s a predictive modeling methodology based on the diagnoses of the individuals in that population. As payers move to value based models, they heavily rely on risk adjustment to ensure proper funding.
All healthcare providers who are currently participating in the MIPS portion of Medicare’s Quality Payment Program may want to participate in the new COVID-19 Clinical Trials improvement activity. Read more about it here.
